FDA Inspection 857318 — Haupt Pharma Amareg GmbH
The FDA completed an inspection of Haupt Pharma Amareg GmbH on Nov 22, 2013 in Ratisbon. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 22, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ratisbon (Germany)